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Pulmonary microbiology of HIV positive subjects with
community-acquired pneumonia (CAP) with special
emphasis on Mycoplasma pneumoniae
U. Rao1,∗, E. Shankar2, N. Kumarasamy3, P. Balakrishnan3,
S. Solomon3
1 Raga’s Dental College, 600119, India
2 University of Madras, Chennai, India
3 YRG CARE, Chennai, India
Background: A great deal of effort has been devoted to
understanding the role of AIDSassociated mycoplasmas in
recent years. However, the role of Mycoplasma pneumoniae
in HIV disease remains unclear.
Methods: We studied 300 adult HIV infected persons (200
with community-acquired pneumonia (CAP) and 100 with no
respiratory illness) and 75 HIV uninfected persons with CAP
and analysed the prevalence of respiratory pathogens.
Results: Prevalence of M. pneumoniae was 17% by
induced sputum and 11.3% by throat swab culture in HIV
positive subjects. Seroprevalence of anti-M. pneumoniae
IgM was 11.7% by ELISA and 14.3% by gelatin microparti-
cle agglutination test. Prevalence of M. pneumoniae among
HIV negative cases was relatively low. Streptococcus pneu-
moniaewas predominant (28%) among subjects with lower
respiratory disease, whereas Staphylococcus aureus (15%)
was more common among cases with upper respiratory
illness. Rales (P=0.001), pharyngeal erythema (P=0.02),
cervical adenopathy (P=0.004) and crepitations (P=0.001)
showed signiﬁcance in relation to M. pneumoniae positiv-
ity. Statistical signiﬁcance was observed with regard to total
lymphocyte count (P=0.02) and erythrocyte sedimentation
rate (P=0.04), and M. pneumoniae positivity.
Conclusion: The prevalence of M. pneumoniae in HIV
infected subjects was relatively higher than HIV uninfected
subjects with respiratory disease.
doi:10.1016/j.ijid.2010.02.511
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Kaposi’s sarcoma (KS) and AIDS. Survival study
D.B. Lima1,∗, A. Barbosa2, E.F. Cunha1, R.G. Cunha1, J.P.
Almeida1, V.R. Gomes1
1 Infectious Diseases Unit at University Hospital Pedro
Ernesto, Faculty of Medical Sciences, State University of
Rio de Janeiro /UERJ — RJ, Brazil., Rio de Janeiro, Brazil
2 University Hospital Pedro Ernesto, Rio de Janeiro State
University- UERJ, Brazil., Rio de Janeiro, Rio de Janeiro,
Brazil
Background: To evaluate the factors associated with sur-
vival time of AIDS patients with KS.
Methods: We studied the medical records of patients with
AIDS / KS, adults of both sexes admitted for clinical follow-
up at the Infectious Disease Unit from 1985 to 2008. We used
a protocol with demographic data, CD4 cell count, extension
of the lesion (localized or disseminated) and survival time
of each patient. The EPI-INFO 3.4.3 was used to analyse the
results.
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Results: Among 136 patients with AIDS and cancer
e found anal carcinoma 4(2.9%) Hodgkin’s lymphoma 7
5.1%),non-Hodgkin’s lymphoma 26 (19.1%), KS 90 (66.2%),
ther 9 (6.6%). Among the cases of KS, 86 men and 4
omen, disseminated disease 62 (68.9%), 3 women (4.8%),
9 men (95.2%); localized 28 (31.1%), 1 woman (3.6%), 27
en (96.4%). Average age of 37.27 ± 9.09 SK, localized
8.92 ± 10.06, disseminated 36.5 ± 8.59 ANOVA p=0.25.
edian CD4 localized 315 cells/mm+ (27-1088), dissemi-
ated 297 cells/mm+ (11-778) Kruskal-Wallis p=0.41, no
tatistical difference. Survival time of KS total median 304
ays (0-4090), localized median 270 (0-4090), disseminated
30 (10.0-3105) Kruskal-Wallis p=0.96, no statistical differ-
nce. The median survival time of those on antiretroviral
reatment was 721 days (0.0-4090) and without antiretrovi-
al treatment 120 days (2.0-2555) Kruskal-Wallis p=0.0000.
Conclusion: The use of antiretrovirals drugs was the only
eterminant of improved survival time among patients with
IDS and KS.
oi:10.1016/j.ijid.2010.02.512
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pportunistic infections in central nervous system and
ssociated neurologic disorders in HIV infected patients
n a Western Hospital of Venezuela, 2007-2009
. Herrera-Martínez1, Y. Herrera2,∗, A.M. Pineda3
Hopsital Central Antonio María Pineda, Barquisimeto,
ara, Venezuela
Hospital Central Antonio María Pineda, Barquisimeto,
ara, Venezuela
Hospital Central Antonio María Pineda, Barquisimeto,
enezuela
Background: HIV-related central nervous system (CNS)
isorders and infections represent substantial personal, eco-
omic, and societal problems. However, its understanding is
till lacking in areas of some developing countries where HIV
rograms are still limited.
Methods: Herein we describe epidemiology, clinical fea-
ures and diagnosis of opportunistic infections in CNS and
ssociated neurologic disorders in HIV infected patients in a
estern hospital of Venezuela, January 2007 to September
009. Monthly records of conﬁrmed HIV cases from the epi-
emiological archives were collected. All the patients with
pportunistic infections in CNS or associated neurologic dis-
rders were selected. All the clinical relevant variables were
onsidered in this analysis.
Results: A total of 228 patients with HIV infection were
reated during the study period; thirteen of them (5%)
resented neuropathology. Twelve (92%) were male, mean
ge was 35 years-old, previous HIV was diagnosed in nine
atients (69%) with a mean of 9 months, just 4 (30%) were
eceiving antiretroviral treatment. The most common pre-
ented symptom was fever 6/13 (46%), followed by muscular
trength loss and headache 5/13 (38%), convulsions and con-
cience alteration also had an important incidence 4/13
30%) among other ﬁndings. Neurological diagnoses were:
/13 (53%) Cerebral Toxoplasmosis, 3/13 (23%) Central ner-
ous system Cryptococcus neoformans infection, 2/13 (15%)
erebral Tuberculosis and 1/13 motor-sensitive neuropathy
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7%). Most of them (84%) also had associated infections
r diagnoses: pancytopenia (46%), Pneumocystis jirovecii
neumonia (38%) and candidiasis (30%); Kaposi sarcoma, dia-
etes, pulmonary tuberculosis and chronic diarrhea were
lso presented. CD4 count mean was 120 cells/mm3, CD8
ount mean was 571 cells/mm3, and viral load was 12,120
opies/mm3 log 3.22. CFR was 15%.
Conclusion: In this study neuroinfection was the ﬁrst
ause of hospitalization in HIV infected patients with
eurologic symptoms. Toxoplasmosis was the most com-
on opportunistic parenchymal brain lesion. The majority
f patients had associated other opportunistic diagnosis.
roper studies to determinate the real country prevalence
nd characteristics of these neuropathologies are necessary.
arly diagnosis is important in order to prevent potential
omplications and sequels. Even more, clinical follow-up
tudies of these infected patients are also needed in order
o evaluate the evolution of disease and development of
ssociated conditions.
oi:10.1016/j.ijid.2010.02.513
8.008
IV and opportunistic infections in a western hospital of
enezuela, 2007-2009
. Herrera-Martínez1,∗, Y. Herrera1, A.M. Pineda2
Hospital Central Antonio María Pineda, Barquisimeto,
ara, Venezuela
Hospital Central Antonio María Pineda, Barquisimeto,
enezuela
Background: Numerous opportunistic infections occur in
IV infected patients, particularly in those without access
o antiretroviral therapy. In Venezuela it is known a high
elationship between TB, PJP and candidiasis in HIV infected
atients.
Methods: We describe epidemiology, diagnosis and clini-
al features in HIV infected patients admitted to the Central
ospital of Barquisimeto, Western Venezuela, from January
007 to September 2009. Monthly records of conﬁrmed HIV
ases from the epidemiological archives were collected.
nly patients with opportunistic infections were selected.
ll the clinical relevant variables were considered in this
nalysis.
Results: A total of 228 patients with HIV infection were
reated in this medical center during the study period; Forty
hree (84%) were male; mean age was 36 years 51 (22%)
ad associated opportunistic infections.; Most cases due
o sexual transmission (96%), 56% were heterosexual, 75%
romiscuous, with a mean of four couples, beginning sex-
al relations at 17 years old. Fourteen (27%) patients had
revious HIV diagnosis, with a mean of 25 months, just 8
15%) were receiving treatment; 2/51 (4%) also had other
exual transmission diseases. Most common presented symp-
oms were fever 21/51 (41%), cough 19/51 (37%), weight
oss, vomits and dyspnea had also an important incidence
mong others. Half patients had anemia. Pneumonia was
he most common diagnosis 23/51 (45%), 65% caused by
neumocystis jirovecii; followed by wasting syndrome 18/51
35%), candidiasis (mucocutaneous, tracheal, esophagic),
ancytopenia 14/51 (27%), and chronic diarrhea 11/51 (21%)ternational Congress on Infectious Diseases (ICID) Abstracts
mong other diagnosis. TB had a low incidence during the
tudy period (11%). Patients, in which lymphocytic count
as available, had a CD4 count mean of 168 cells/mm3
nd CD8 count of 813 cells/mm3 and a viral load of 62,913
opies/mm3 log 3.06. CFR was 15%.
Conclusion: A signiﬁcant incidence of pneumonia due to
neumocystis jirovecii was observed. Since the introduc-
ion of HAART in Venezuela, a considerable reduction of
pportunistic infections was observed but HIV diagnosis usu-
lly occurs after opportunistic infections presentation, then,
roper diagnosis and prevention campaigns are for outmost
mportant not only in Venezuela, also in other developing
ountries in order to reduce the incidence of complications
nd to increase the quality of life of HIV infected patients.
oi:10.1016/j.ijid.2010.02.514
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revalence of occult hepatitis B infection among HIV
nfected patients at an inner city clinic
. Nog ∗, K. Singaravelu, A. Haider, V. Sivapalan, S.
annheimer
Columbia University College Of Physicians and Surgeons
fﬁliation at Harlem Hospital Center, New York, NY, USA
Background: Morbidity and mortality is higher in HIV/HBV
oinfected than HIV monoinfected patients. Occult HBV
nfection i.e. isolated positive Hepatitis B core antibody
anti HBc) but Hepatitis B surface antigen (HBs Ag) and sur-
ace antibody (HBsAb) negative with HBV DNA is a form
f chronic HBV infection that impacts HIV management.
bjective: To determine the prevalence and patient char-
cteristics of occult hepatitis B infection in HIV infected
atients attending an outpatient HIV clinic in New York.
Methods: An electronic database of 630 HIV positive
atients at NYC Harlem Hospital Center’s Infectious Diseases
linic between June 2007 and January 2009 was reviewed.
otal of 82 patients with HBV serology showing HBsAg-,
BsAb -, anti HBc+ were identiﬁed. Of these 57 (69.5%) had
BV DNA testing information. Information on Demographic
ariables, Hepatitis C antibody (HCV Ab), antiretroviral ther-
py (ARV), CD4 and HIV viral load were collected.
Results: Among the ﬁnal study population, majority were
ales (n=36, 63.2%), African American (n=34, 59.6%), mean
ge of 48.7 ± 6.2yrs, on ARV (n=39, 70.2%), had CD4 > 200
n=44, 77.2%), VL < 50 (n=30, 52.6%) and 47.4% (n=27) tested
ositive for HCV. Approximately 7% (n=4) of study popu-
ation met the deﬁnition of occult HBV infection. 22% of
atients not on ARV (n=18) had positive HBV DNA, whereas
one of patients on ARV (0%, n=39) had detectable HBV DNA
p=0.007). All patients on ARV (n=39) were on a regimen
ith anti HBV activity. Of those with occult HBV infection,
0% (n=2) were males, 100% (n=4) were African American,
ean CD4 count was 408± 280, 75% (n=3) had HIV viral load
50, 100% were not on ARV and 75% tested positive for HCV.
